Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 346
Filter
1.
J Clin Anesth ; 95: 111472, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38613938

ABSTRACT

STUDY OBJECTIVE: Evidence for red blood cell (RBC) transfusion thresholds in the intraoperative setting is limited, and current perioperative recommendations may not correspond with individual intraoperative physiological demands. Hemodynamics relevant for the decision to transfuse may include peripheral perfusion index (PPI). The objective of this prospective study was to assess the associations of PPI and hemoglobin levels with the risk of postoperative morbidity and mortality. DESIGN: Multicenter cohort study. SETTING: Bispebjerg and Hvidovre University Hospitals, Copenhagen, Denmark. PATIENTS: We included 741 patients who underwent acute high risk abdominal surgery or hip fracture surgery. INTERVENTIONS: No interventions were carried out. MEASUREMENTS: Principal values collected included measurements of peripheral perfusion index and hemoglobin values. METHODS: The study was conducted using prospectively obtained data on adults who underwent emergency high-risk surgery. Subjects were categorized into high vs. low subgroups stratified by pre-defined PPI levels (PPI: > 1.5 vs. < 1.5) and Hb levels (Hb: > 9.7 g/dL vs. < 9.7 g/dL). The study assessed mortality and severe postoperative complications within 90 days. MAIN RESULTS: We included 741 patients. 90-day mortality was 21% (n = 154), frequency of severe postoperative complications was 31% (n = 231). Patients with both low PPI and low Hb had the highest adjusted odds ratio for both 90-day severe postoperative complications (2.95, [1.62-5.45]) and 90-day mortality (3.13, [1.45-7.11]). A comparison of patients with low PPI and low Hb to those with high PPI and low Hb detected significantly higher 90-day mortality risk in the low PPI and low Hb group (OR 8.6, [1.57-162.10]). CONCLUSION: High PPI in acute surgical patients who also presents with anemia was associated with a significantly better outcome when compared with patients with both low PPI and anemia. PPI should therefore be further investigated as a potential parameter to guide intraoperative RBC transfusion therapy.


Subject(s)
Anemia , Hemoglobins , Postoperative Complications , Humans , Female , Male , Anemia/epidemiology , Aged , Prospective Studies , Hemoglobins/analysis , Middle Aged , Postoperative Complications/etiology , Postoperative Complications/epidemiology , Postoperative Complications/mortality , Perfusion Index , Erythrocyte Transfusion/statistics & numerical data , Aged, 80 and over , Hip Fractures/surgery , Cohort Studies , Denmark/epidemiology , Risk Assessment/methods , Risk Assessment/statistics & numerical data , Abdomen/surgery , Intraoperative Complications/epidemiology , Intraoperative Complications/etiology , Intraoperative Complications/diagnosis , Intraoperative Complications/blood , Intraoperative Complications/mortality
2.
Oxid Med Cell Longev ; 2021: 3315951, 2021.
Article in English | MEDLINE | ID: mdl-34381560

ABSTRACT

OBJECTIVE: Coronary artery bypass grafting (CABG) represents the significant source of increased oxidative stress (OS). We aimed to follow the OS status parameters (i.e., ischemia-modified albumin (IMA), malondialdehyde (MDA), superoxide anion, prooxidant-antioxidant balance (PAB), total oxidant status (TOS), total antioxidant status (TAS), and superoxide-dismutase (SOD)) change through the predefined study times in two different surgical procedures, i.e., cardiopulmonary bypass (CPB) and off-pump coronary artery bypass grafting (OPCAB). Additionally, we aimed to investigate those OS status parameters in specific study times according to SYNTAX score (SS), an established angiographic score for evaluating the extensity and severity of coronary artery disease. Patients and Methods. A total of 107 patients that were planned to undergo CABG were included (i.e., 47 patients in OPCAB and 60 patients in CPB group). Blood samples were taken at 6 time intervals: before surgery (t1), immediately after intervention (t2), 6 h (t3), 24 h (t4), 48 h (t5), and 96 h after termination of the operation (t6). RESULTS: IMA levels were higher in CPB than that in OPCAB baseline and rose in CPB group in t2 point. TOS decreased in both study groups, compared to baseline values, but without statistical significance. Superoxide anion and PAB significantly increased in t3-t6 study times, in both groups. MDA significantly increased only in CPB group in t5 and t6 interval. MDA was significantly higher in CPB group compared to OPCAB in t6 study point. CPB patients had significantly lower TAS compared to OPCAB patients at the beginning and in t2 and t3 study points. They also had significantly lower SOD activities compared to OPCAB, baseline, and in several study points. Moreover, TAS, SOD, and TAS/TOS ratio were significantly lower, whereas PAB and TOS/TAS were significantly higher in patients with high SS compared to corresponding groups. SOD activity, IMA, and TAS level were the best predictors of high SS. CONCLUSION: CPB patients were in more severe ischemia baseline than OPCAB group and IMA rose in CPB patients immediately after the surgery end, but not later. Also, the antioxidant status was significantly lower, whereas the prooxidant status was significantly higher in patients with high SS compared to corresponding groups. SOD activity, IMA, and TAS level were the best predictors of CAD (as determined with SS), showing that SOD and IMA had very good discriminatory capability towards higher SS status.


Subject(s)
Cardiopulmonary Bypass/adverse effects , Coronary Artery Bypass, Off-Pump/adverse effects , Intraoperative Complications/blood , Oxidative Stress , Postoperative Complications/blood , Aged , Female , Humans , Intraoperative Complications/epidemiology , Male , Malondialdehyde/blood , Middle Aged , Postoperative Complications/epidemiology , Superoxide Dismutase/blood , Superoxides/blood
3.
Eur J Endocrinol ; 185(4): 507-514, 2021 Aug 27.
Article in English | MEDLINE | ID: mdl-34324433

ABSTRACT

BACKGROUND: Despite adequate presurgical management, blood pressure fluctuations are common during resection of pheochromocytoma or sympathetic paraganglioma (PPGL). To a large extent, the variability in blood pressure control during PPGL resection remains unexplained. Adrenomedullin and B-type natriuretic peptide, measured as MR-proADM and NT-proBNP, respectively, are circulating biomarkers of cardiovascular dysfunction. We investigated whether plasma levels of MR-proADM and NT-proBNP are associated with blood pressure fluctuations during PPGL resection. METHODS: Study subjects participated in PRESCRIPT, a randomized controlled trial in patients undergoing PPGL resection. MR-proADM and NT-proBNP were determined in a single plasma sample drawn before surgery. Multivariable linear and logistic regression analyses were used to explore associations between these biomarkers and blood pressure fluctuations, use of vasoconstrictive agents during surgery as well as the occurrence of perioperative cardiovascular events. RESULTS: A total of 126 PPGL patients were included. Median plasma concentrations of MR-proADM and NT-proBNP were 0.51 (0.41-0.63) nmol/L and 68.7 (27.9-150.4) ng/L, respectively. Neither MR-proADM nor NT-proBNP were associated with blood pressure fluctuations. There was a positive correlation between MR-proADM concentration and the cumulative dose of vasoconstrictive agents (03B2 0.44, P =0.001). Both MR-proADM and NT-proBNP were significantly associated with perioperative cardiovascular events (OR: 5.46, P =0.013 and OR: 1.54, P =0.017, respectively). CONCLUSIONS: plasma MR-proADM or NT-proBNP should not be considered as biomarkers for the presurgical risk assessment of blood pressure fluctuations during PPGL resection. Future studies are needed to explore the potential influence of these biomarkers on the intraoperative requirement of vasoconstrictive agents and the perioperative cardiovascular risk.


Subject(s)
Adrenal Gland Neoplasms , Adrenomedullin/blood , Blood Pressure/physiology , Natriuretic Peptide, Brain/blood , Pheochromocytoma , Adrenal Gland Neoplasms/blood , Adrenal Gland Neoplasms/diagnosis , Adrenal Gland Neoplasms/drug therapy , Adrenal Gland Neoplasms/surgery , Adrenergic Antagonists/therapeutic use , Adult , Aged , Biomarkers/blood , Cardiovascular Diseases/blood , Cardiovascular Diseases/diagnosis , Cardiovascular Diseases/physiopathology , Cardiovascular Diseases/prevention & control , Cross-Sectional Studies , Female , Follow-Up Studies , Heart Failure/blood , Heart Failure/diagnosis , Heart Failure/physiopathology , Heart Failure/prevention & control , Humans , Intraoperative Complications/blood , Intraoperative Complications/diagnosis , Intraoperative Complications/physiopathology , Intraoperative Complications/prevention & control , Male , Middle Aged , Pheochromocytoma/blood , Pheochromocytoma/diagnosis , Pheochromocytoma/drug therapy , Pheochromocytoma/surgery , Prognosis , Risk Assessment , Treatment Outcome
4.
Int J Med Sci ; 18(6): 1332-1338, 2021.
Article in English | MEDLINE | ID: mdl-33628088

ABSTRACT

BACKGROUND AND PURPOSE: Hyperglycemia can lead to an increased rate of apoptosis of microglial cells and to damaged neurons. The relation between hyperglycemia and cerebrovascular markers on MRI is unknown. Our aim was to study the association between intraoperative hyperglycemia and cerebrovascular markers. METHODS: In this further analysis of a subgroup investigation of the BIOCOG study, 65 older non-demented patients (median 72 years) were studied who underwent elective surgery of ≥ 60 minutes. Intraoperative blood glucose maximum was determined retrospectively in each patient. In these patients, preoperatively and at 3 months follow-up a MRI scan was performed and white matter hyperintensity (WMH) volume and shape, infarcts, and perfusion parameters were determined. Multivariable logistic regression analyses were performed to determine associations between preoperative cerebrovascular markers and occurrence of intraoperative hyperglycemia. Linear regression analyses were performed to assess the relation between intraoperative hyperglycemia and pre- to postoperative changes in WMH volume. Associations between intraoperative hyperglycemia and postoperative WMH volume at 3 months follow-up were also assessed by linear regression analyses. RESULTS: Eighteen patients showed intraoperative hyperglycemia (glucose maximum ≥ 150 mg/dL). A preoperative more smooth shape of periventricular and confluent WMH was related to the occurrence of intraoperative hyperglycemia [convexity: OR 33.318 (95 % CI (1.002 - 1107.950); p = 0.050]. Other preoperative cerebrovascular markers were not related to the occurrence of intraoperative hyperglycemia. Intraoperative hyperglycemia showed no relation with pre- to postoperative changes in WMH volume nor with postoperative WMH volume at 3 months follow-up. CONCLUSIONS: We found that a preoperative more smooth shape of periventricular and confluent WMH was related to the occurrence of intraoperative hyperglycemia. These findings may suggest that a similar underlying mechanism leads to a certain pattern of vascular brain abnormalities and an increased risk of hyperglycemia.


Subject(s)
Elective Surgical Procedures/adverse effects , Hyperglycemia/epidemiology , Intraoperative Complications/epidemiology , Postoperative Cognitive Complications/epidemiology , White Matter/diagnostic imaging , Age Factors , Aged , Blood Glucose/analysis , Female , Follow-Up Studies , Humans , Hyperglycemia/blood , Hyperglycemia/diagnosis , Hyperglycemia/etiology , Intraoperative Complications/blood , Intraoperative Complications/diagnosis , Intraoperative Complications/etiology , Magnetic Resonance Imaging/statistics & numerical data , Male , Neuroimaging/statistics & numerical data , Postoperative Cognitive Complications/diagnosis , Postoperative Cognitive Complications/etiology , Postoperative Period , Preoperative Period , Prospective Studies , Retrospective Studies , Risk Assessment/methods , Risk Factors , White Matter/blood supply
5.
BMJ Case Rep ; 13(12)2020 Dec 17.
Article in English | MEDLINE | ID: mdl-33334739

ABSTRACT

Takotsubo cardiomyopathy (TTC) is a rare but life-threatening condition that is still not completely understood. Characterised by rapidly reversible ventricular dysfunction without any prior coronary artery disease, it can imitate a myocardial infarction and lead to death if not managed appropriately. This report examines a case of intraoperative cardiac arrest in a patient with no previous cardiac disease, and discusses the factors that may have precipitated this event, as well as the ways of distinguishing the cause of the arrest based on clinical course and investigations, eventually leading to a diagnosis of TTC.


Subject(s)
Abortion, Induced/adverse effects , Heart Arrest/etiology , Intraoperative Complications/diagnosis , Stress, Psychological/etiology , Takotsubo Cardiomyopathy/diagnosis , Abortion, Induced/psychology , Adult , Cardiotonic Agents/administration & dosage , Catecholamines/blood , Echocardiography , Electrocardiography , Female , Heart Arrest/blood , Heart Arrest/drug therapy , Humans , Infusions, Intravenous , Intraoperative Complications/blood , Intraoperative Complications/drug therapy , Intraoperative Complications/etiology , Pregnancy , Simendan/administration & dosage , Stress, Psychological/blood , Stress, Psychological/psychology , Takotsubo Cardiomyopathy/blood , Takotsubo Cardiomyopathy/drug therapy , Takotsubo Cardiomyopathy/etiology
6.
Gen Thorac Cardiovasc Surg ; 68(8): 754-761, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32507998

ABSTRACT

OBJECTIVES: Hypothermic circulatory arrest (HCA) has been considered to cause coagulopathy during cardiac surgery. However, coagulopathy associated with HCA has not been understood clearly in details. The objective of this study is to analyze the details of coagulopathy related to HCA in cardiac surgery by using rotational thromboelastometry (ROTEM). METHODS: We retrospectively analyzed 38 patients who underwent elective cardiac surgery (HCA group = 12, non-HCA group = 26) in our hospital. Blood samples were collected before and after cardiopulmonary bypass (CPB). Standard laboratory tests (SLTs) and ROTEM were performed. We performed four ROTEM assays (EXTEM, INTEM, HEPTEM and FIBTEM) and analyzed the following ROTEM parameters: clotting time (CT), clot formation time (CFT), maximum clot firmness (MCF) and maximum clot elasticity (MCE). The amount of perioperative bleeding, intraoperative transfusion and perioperative data were compared between the HCA and non-HCA group. RESULTS: Operation time and hemostatic time were significantly longer in the HCA group, whereas CPB time had no difference between the groups. The amount of perioperative bleeding and intraoperative transfusion were much higher in the HCA group. SLTs showed no difference between the groups both after anesthesia induction and after protamine reversal. In ROTEM analysis, MCE contributed by platelet was reduced in the HCA group, whereas MCE contributed by fibrinogen had no difference. CONCLUSION: Our study confirmed that the amount of perioperative bleeding and intraoperative transfusion were significantly higher in the HCA group. ROTEM analysis would indicate that clot firmness contributed by platelet component is reduced by HCA in cardiac surgery.


Subject(s)
Blood Coagulation Disorders/physiopathology , Cardiac Surgical Procedures/adverse effects , Cardiopulmonary Bypass/adverse effects , Aged , Blood Coagulation Disorders/blood , Blood Coagulation Disorders/etiology , Female , Humans , Hypothermia, Induced , Intraoperative Complications/blood , Intraoperative Complications/etiology , Intraoperative Complications/physiopathology , Male , Retrospective Studies , Thrombelastography
7.
Br J Anaesth ; 124(6): 684-692, 2020 06.
Article in English | MEDLINE | ID: mdl-32247539

ABSTRACT

BACKGROUND: This study investigated whether remifentanil infusion decreased intraoperative hyperglycaemia and insulin resistance compared with intermittent fentanyl administration in patients undergoing elective cardiac surgery. METHODS: This was a randomised, prospective, open-label trial. Patients undergoing elective cardiac surgery (n=116) were randomised to receive either continuous intravenous remifentanil infusion or intermittent fentanyl boluses. Hourly blood glucose values were obtained for 24 h starting from induction of anaesthesia. The difference in percentage of patients with ≥2 intraoperative blood glucose concentrations >10 mM (180 mg dl-1) between the groups was the primary outcome measure. Secondary outcome measures included insulin requirements, select stress hormone and inflammatory cytokine concentrations, and safety events and adverse outcomes. RESULTS: The trial included 106 subjects in the final intention-to-treat analysis. There were fewer patients with ≥2 intraoperative blood glucose values >10 mM (180 mg dl-1) in the remifentanil group (17 [31.5%]) compared with the fentanyl group (33 [63.5%]) (relative risk: 0.50; 95% confidence interval [CI]: 0.32-0.77; P=0.001). The administered intraoperative insulin was a median of 8.1 units (range: 0-46.7) in the fentanyl group and 2.9 units (range: 0-35.1) in the remifentanil group (median difference=5 units; 95% CI: 1-7; P=0.004). Cortisol and adrenocorticotropic hormone were increased less in the remifentanil group (P<0.001), but there was no relative decrease in this group in select inflammatory cytokines. Postoperative measures of glycaemic control and adverse clinical outcomes were not significantly different between groups. CONCLUSIONS: Compared with patients treated with intermittent fentanyl, patients receiving continuous remifentanil infusion had fewer episodes of hyperglycaemia and less need for insulin administration during the intraoperative period of cardiac surgery. CLINICAL TRIAL REGISTRATION: NCT02349152.


Subject(s)
Analgesics, Opioid/pharmacology , Blood Glucose/drug effects , Cardiac Surgical Procedures , Hyperglycemia/prevention & control , Insulin Resistance , Intraoperative Complications/prevention & control , Remifentanil/pharmacology , Adult , Aged , Aged, 80 and over , Analgesics, Opioid/blood , Female , Fentanyl/blood , Fentanyl/pharmacology , Humans , Hyperglycemia/blood , Insulin/blood , Intraoperative Complications/blood , Male , Middle Aged , Perioperative Period , Prospective Studies , Remifentanil/blood
8.
Am J Emerg Med ; 38(6): 1226-1232, 2020 06.
Article in English | MEDLINE | ID: mdl-32029342

ABSTRACT

BACKGROUND: Coagulation panels are ordered for a variety of conditions in the emergency department (ED). OBJECTIVE: This narrative review evaluates specific conditions for which a coagulation panel is commonly ordered but has limited utility in medical decision-making. DISCUSSION: Coagulation panels consist of partial thromboplastin time (PTT) or activated partial thromboplastin time (aPTT), prothrombin time (PT), and international normalized ratio (INR). These tests evaluate the coagulation pathway which leads to formation of a fibrin clot. The coagulation panel can monitor warfarin and heparin therapy, evaluate for vitamin K deficiency, evaluate for malnutrition or severe systemic disease, and assess hemostatic function in the setting of bleeding. The utility of coagulation testing in chest pain evaluation, routine perioperative assessment, prior to initiation of anticoagulation, and as screening for admitted patients is low, with little to no change in patient management based on results of these panels. Coagulation testing should be considered in systemically ill patients, those with a prior history of bleeding or family history of bleeding, patients on anticoagulation, or patients with active hemorrhage and signs of bleeding. Thromboelastography and rotational thromboelastometry offer more reliable measures of coagulation function. CONCLUSIONS: Little utility for coagulation assessment is present for the evaluation of chest pain, routine perioperative assessment, initiation of anticoagulation, and screening for admitted patients. However, coagulation panel assessment should be considered in patients with hemorrhage, patients on anticoagulation, and personal history or family history of bleeding.


Subject(s)
Anticoagulants/analysis , Blood Coagulation Tests/standards , Emergency Medicine/methods , Anticoagulants/therapeutic use , Blood Coagulation Tests/methods , Blood Coagulation Tests/statistics & numerical data , Chest Pain/blood , Chest Pain/diagnosis , Emergency Service, Hospital/organization & administration , Heparin/analysis , Heparin/therapeutic use , Humans , International Normalized Ratio/methods , International Normalized Ratio/standards , Intraoperative Complications/blood , Intraoperative Complications/diagnosis , Partial Thromboplastin Time/methods , Partial Thromboplastin Time/standards , Prothrombin Time/methods , Prothrombin Time/standards , Warfarin/analysis , Warfarin/therapeutic use
9.
Anesth Analg ; 131(2): 483-493, 2020 08.
Article in English | MEDLINE | ID: mdl-31880628

ABSTRACT

BACKGROUND: The relationships between the ratios of transfused allogeneic blood products and clinical outcomes in patients with acute intraoperative hemorrhage are poorly defined. METHODS: To better define these ratios, we undertook a single-center, observational cohort study of all surgical patients (≥18 years) who received rapid transfusion defined by a critical administration threshold of 3 or more units of red blood cells (RBCs) intraoperatively within 1 hour between January 1, 2011 and December 31, 2015. Multivariable regression analyses were used to assess relationships between ratios of plasma to RBCs and platelets to RBCs at 3, 12, and 24 hours and clinical outcomes. The primary outcome was hospital mortality, with secondary outcomes of intensive care unit and hospital-free days. RESULTS: The study included 2385 patients, of whom 14.9% had a plasma-to-RBC ratio of 1.0+, and 47.6% had a platelet-to-RBC ratio of 1.0+. Higher plasma-to-RBC and platelet-to-RBC ratios were observed for patients who underwent cardiac, transplant, and vascular surgery and in patients with greater derangements in hemostatic laboratory values. Ratios did not differ by patient age or severity of illness. Higher ratios were not associated with improved clinical outcomes. Mortality differed by platelet-to-RBC but not plasma-to-RBC ratio, with the highest mortality observed with a platelet-to-RBC ratio of 0.1-0.9 at 24 hours (odds ratio, 3.34 [1.62-6.88]) versus no platelets (P= .001). Higher plasma-to-RBC ratios were associated with decreased hospital-free days, although differences in clinical outcomes were not significant after exclusion of patients receiving only RBCs without component therapies. CONCLUSIONS: Transfusion ratios in surgical patients with critical intraoperative hemorrhage were largely related to surgical and hemostatic features rather than baseline patient characteristics. Higher ratios were not associated with improved outcomes.


Subject(s)
Blood Loss, Surgical/prevention & control , Blood Platelets/metabolism , Blood Transfusion, Autologous/methods , Intraoperative Complications/blood , Intraoperative Complications/therapy , Plasma/metabolism , Aged , Cohort Studies , Erythrocyte Transfusion/methods , Female , Humans , Intensive Care Units/trends , Male , Middle Aged , Retrospective Studies
10.
Anesth Analg ; 131(1): 173-186, 2020 07.
Article in English | MEDLINE | ID: mdl-31880630

ABSTRACT

Myocardial injury after noncardiac surgery (MINS) differs from myocardial infarction in being defined by troponin elevation apparently from cardiac ischemia with or without signs and symptoms. Such myocardial injury is common, silent, and strongly associated with mortality. MINS is usually asymptomatic and only detected by routine troponin monitoring. There is currently no known safe and effective prophylaxis for perioperative myocardial injury. However, appropriate preoperative screening may help guide proactive postoperative preventative actions. Intraoperative hypotension is associated with myocardial injury, acute kidney injury, and death. Hypotension is common and largely undetected in the postoperative general care floor setting, and independently associated with myocardial injury and mortality. Critical care patients are especially sensitive to hypotension, and the risk appears to be present at blood pressures previously regarded as normal. Tachycardia appears to be less important. Available information suggests that clinicians would be prudent to avoid perioperative hypotension.


Subject(s)
Intraoperative Complications/blood , Myocardial Ischemia/blood , Postoperative Complications/blood , Preoperative Care/methods , Biomarkers/blood , Humans , Intraoperative Complications/etiology , Intraoperative Complications/prevention & control , Myocardial Ischemia/etiology , Myocardial Ischemia/prevention & control , Natriuretic Peptide, Brain/blood , Postoperative Complications/etiology , Postoperative Complications/prevention & control , Preoperative Care/trends , Troponin/blood
11.
Langenbecks Arch Surg ; 405(1): 81-90, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31820096

ABSTRACT

PURPOSE: MTS is elicited during open abdominal surgery and is characterized by facial flushing, hypotension, and tachycardia in response to the release of prostacyclin (PGI2) to plasma. MTS seems to affect postoperative morbidity, but data from larger cohorts are lacking. We aimed to determine the impact of severe mesenteric traction syndrome (MTS) on postoperative morbidity in patients undergoing open upper gastrointestinal surgery. METHODS: The study was a secondary analysis of data from three cohorts (n = 137). The patients were graded for severity of MTS intraoperatively, and hemodynamic variables and blood samples for plasma 6-keto-PGF1α, a stable metabolite of PGI2, were obtained at defined time points. Postoperative morbidity was evaluated by the comprehensive complication index (CCI) and the Dindo-Clavien classification (DC). RESULTS: Patients undergoing either esophagectomy (n = 70), gastrectomy (n = 22), liver- (n = 23), or pancreatic resection (n = 22) were included. Severe MTS was significantly associated with increased postoperative morbidity, i.e., CCI ≥ 26.2 (OR 3.06 [95% CI 1.1-6.6]; p = 0.03) and risk of severe complications, i.e., DC ≥3b (OR 3.1 [95% CI 1.2-8.2]; p = 0.023). Furthermore, patients with severe MTS had increased length of stay (OR 10.1 [95% CI 1.9-54.3]; p = 0.007) and were more likely to be admitted to the intensive care unit (OR = 7.3 [95% CI 1.3-41.9]; p = 0.027), but there was no difference in 1-year mortality. CONCLUSION: Occurrence of severe MTS during upper gastrointestinal surgery is associated with increased postoperative morbidity as indicated by an increased rate of severe complications, length of stay, and admission to the ICU. It remains to be determined whether inhibition of MTS enhances postoperative recovery.


Subject(s)
Digestive System Surgical Procedures/adverse effects , Mesentery/surgery , Aged , Denmark/epidemiology , Digestive System Surgical Procedures/statistics & numerical data , Epoprostenol/blood , Female , Flushing/blood , Flushing/etiology , Humans , Hypotension/blood , Hypotension/etiology , Intraoperative Complications/blood , Intraoperative Complications/epidemiology , Intraoperative Complications/etiology , Male , Middle Aged , Morbidity , Syndrome , Tachycardia/blood , Tachycardia/etiology
12.
Transplant Proc ; 51(7): 2228-2231, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31474289

ABSTRACT

BACKGROUND: The aim of this study is to investigate the frequency and risk factors of new-onset diabetes after donation in kidney donors without diabetes. METHODS: Living donors of kidney transplants between 1998 and 2016 were evaluated. To detect the blood glucose profile of the donors, preoperative fasting glucose (pro-G), nephrectomy evening glucose (nG), and postoperative day 1 fasting glucose (post-G) values were measured. RESULTS: A total of 195 cases were included in the study. The mean follow-up time in months ± SD (range) was 56 ± 45 (12-215). Of these, 28 (14.3%) donors developed diabetes. The pro-G (103 ± 7.6 vs 93 ± 9.0), nG (208 ± 122 vs 163 ± 67) and post-G (121 ± 25 vs 111 ± 21) values of the donors with new-onset diabetes were higher. Nineteen donors (9.7%) had normal pro-G, nG, and post-G values (group A). However, there were 153 (78.5%) cases with at least 1 abnormal value (group B) and 25 (12.8%) cases that had abnormal values in all (pro-G, nG, and post-G) measurements (group C). The incidence of new-onset diabetes was 0 (0%) in group A, 11% in group B, and 48% in group C (P < .001). In multiple regression analysis, pro-G (Exp[B], 1.08; 95% CI, 1.04-1.13; P < .001) and basal glomerular filtration rate (Exp[B], 0.96; 95% CI, 0.94-0.99; P < .01) independently associated with new-onset diabetes. CONCLUSIONS: In kidney donors without a history of diabetes, the development of diabetes after donor nephrectomy is an important problem. Pre- and postoperative blood glucose levels provide important information to predict these cases.


Subject(s)
Diabetes Mellitus/etiology , Hyperglycemia/etiology , Intraoperative Complications/etiology , Living Donors , Nephrectomy/adverse effects , Postoperative Complications/etiology , Tissue and Organ Harvesting/adverse effects , Adult , Blood Glucose/analysis , Diabetes Mellitus/blood , Fasting/blood , Female , Glomerular Filtration Rate , Humans , Hyperglycemia/blood , Intraoperative Complications/blood , Kidney/surgery , Kidney Transplantation , Male , Middle Aged , Postoperative Complications/blood , Risk Factors
13.
Rev Esp Anestesiol Reanim (Engl Ed) ; 66(8): 439-442, 2019 Oct.
Article in English, Spanish | MEDLINE | ID: mdl-31327534

ABSTRACT

Hip arthroplasty is associated with a high incidence of embolic events that, although usually not relevant at a clinical level, may be an important cause of morbidity and mortality in certain situations. Extreme caution should be taken in patients with cardiac defects that favor communication between the pulmonary and systemic circulation, due to their greater risk of complications. We present the case of a 72-year-old patient who suffered a paradoxical embolism during the intervention, with devastating consequences.


Subject(s)
Arthroplasty/adverse effects , Bone Cements/adverse effects , Eisenmenger Complex/complications , Embolism, Paradoxical/etiology , Hip Fractures/surgery , Infarction, Posterior Cerebral Artery/etiology , Intraoperative Complications/etiology , Aged , Anesthetics/adverse effects , Anesthetics/pharmacology , Arthroplasty/methods , Blood Gas Monitoring, Transcutaneous , Brain Ischemia/etiology , Brain Ischemia/physiopathology , Bundle-Branch Block/complications , Carbon Dioxide/blood , Coma/etiology , Diagnosis, Differential , Embolism, Paradoxical/blood , Embolism, Paradoxical/physiopathology , Fatal Outcome , Female , Humans , Infarction, Posterior Cerebral Artery/blood , Infarction, Posterior Cerebral Artery/physiopathology , Intraoperative Complications/blood , Intraoperative Complications/physiopathology , Lactates/blood , Monitoring, Intraoperative , Oxygen/blood , Stroke/diagnosis , Vascular Resistance/drug effects
15.
Injury ; 50(9): 1558-1564, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31279476

ABSTRACT

AIM: Postoperative delirium (PD) is a frequent complication of hip fracture surgery, but its pathophysiology remains poorly understood. We investigated the impact of a single episode of intraoperative hyper/hypotension, blood pressure (BP) fluctuation (ΔMAP), and pulse pressure (PP) on hyper/hypoactive PD in elderly patients undergoing surgery for hip fracture. We also assessed the effect of PD on clinical outcomes. METHODS: This was a prospective 1-year follow-up study of patients over 60 years of age with a primary diagnosis of acute low-energy hip fracture. Perioperative delirium was assessed using the Confusion Assessment Method (CAM); the development of PD and the type, hyperactive or hypoactive PD, were recorded. Cognitive assessment was evaluated using the Short Portable Mental Status Questionnaire (SPMSQ). The lowest and highest BP values were extracted from the patients' anaesthesia charts. Postoperative complications, reinterventions and 1-month mortality were recorded. RESULTS: PD occurred in 148 (53%) patients during the first postoperative week, with 75% of the cases diagnosed as hypoactive PD. Patients developing PD of any type were older, had a lower body mass index, higher SPMSQ and Charlson scores, more severe systemic diseases, a lower lowest intraoperative BP, a higher ΔMAP, a lower PP, and a higher postoperative pain score. They also took more drugs and received more blood transfusion intraoperatively. Multivariate logistic regression analyses showed that a higher MAP min had a protective effect on the occurrence of any type of PD, as well as hypoactive and hyperactive. PD had negative effect on outcomes. CONCLUSION: Our results provide evidence of an association between maximal hypotension, the lowest intraoperative mean blood pressure (MAP), ΔMAP, PP, and PD. A progressive decrease in MAP during surgery was associated with the increased odds of developing either type of PD.


Subject(s)
Delirium/etiology , Fracture Fixation/adverse effects , Hip Fractures/surgery , Hypotension/complications , Intraoperative Complications/physiopathology , Aged , Aged, 80 and over , Blood Pressure , Blood Pressure Determination , Delirium/physiopathology , Female , Follow-Up Studies , Fracture Fixation/methods , Humans , Hypotension/physiopathology , Intraoperative Complications/blood , Male , Prospective Studies
17.
Br J Anaesth ; 123(1): 27-36, 2019 Jul.
Article in English | MEDLINE | ID: mdl-31060732

ABSTRACT

BACKGROUND: Perioperative diabetic ketoacidosis (DKA) with near-normal blood glucose concentrations, termed euglycaemic ketoacidosis (EDKA), is an adverse effect associated with sodium-glucose co-transporter-2 inhibitors (SGLT2i). Guidelines are still evolving concerning the perioperative management of patients on SGLT2i. We performed a systematic review of published reports of DKA from SGLT2i in the surgical setting to understand better the clinical presentation and characteristics of SGLT2i-associated DKA. METHODS: We searched PubMed, Embase, and ProQuest for reports of perioperative DKA involving SGLT2i up to January 2019. RESULTS: Forty-two reports of EDKA and five cases of hyperglycaemic diabetic ketoacidosis (HDKA) were identified from 33 publications. Canagliflozin was implicated in 26 cases. Presentation time varied from a few hours up to 6 weeks after operation. Precipitating factors may include diabetes medication changes, diet modifications, and intercurrent illnesses. There were 13 cases (12 EDKA and one HDKA) of bariatric surgery, 10 of them noted very-low-calorie diet regimes as a precipitating factor. No precise association between interruption of SGLT2i and the occurrence of DKA could be identified. Seven patients required mechanical ventilation, and acute kidney injury was noted in five. Five cases needed imaging to rule out anastomotic leak and pulmonary embolism, all of them revealed negative findings. Outcome data were available in 32 cases, all of them recovered completely. CONCLUSIONS: EDKA is likely to be under-recognised because of its atypical presentation and may delay the diagnosis. Understanding this clinical entity, vigilance towards monitoring plasma/capillary ketones helps in early identification and assists in the management.


Subject(s)
Diabetic Ketoacidosis/blood , Diabetic Ketoacidosis/chemically induced , Intraoperative Complications/chemically induced , Postoperative Complications/chemically induced , Sodium-Glucose Transporter 2 Inhibitors/adverse effects , Diabetic Ketoacidosis/diagnosis , Humans , Intraoperative Complications/blood , Intraoperative Complications/diagnosis , Postoperative Complications/blood , Postoperative Complications/diagnosis
18.
Orv Hetil ; 160(6): 203-213, 2019 Feb.
Article in Hungarian | MEDLINE | ID: mdl-30730201

ABSTRACT

Severe perioperative bleeding increases perioperative morbidity and mortality. The management of the consequences imposes high burden on the human and financial resources of healthcare providers. Since 2009, there has been a continued worldwide decline in demand for allogenic blood products. This tendency can mainly be attributed to Perioperative Blood Management Program and to new innovative management applying haemostatic factor concentrates, viscoelastic assays and guidelines for treatment of the severe periprocedural bleeding patients. One of the major challenges of our times is still to match blood supply with demand. The new diagnostic and therapeutic modalities for managing the bleeding patients require new financial resources on the one hand and, on the other hand, call for redistribution of the material means provided by the health care system. Achieving interoperability between financial resources allocated to allogenic blood products and factor concentrates, the current state-of-the-art approach for managing the bleeding patient can be used to save blood and the lives of patients simultaneously. Orv Hetil. 2019; 160(6): 203-213.


Subject(s)
Blood Component Transfusion/statistics & numerical data , Hemorrhage/therapy , Intraoperative Complications/therapy , Perioperative Care/methods , Postoperative Complications/therapy , Blood Loss, Surgical , Hemostatics/therapeutic use , Humans , Intraoperative Complications/blood , Postoperative Complications/blood
19.
Postgrad Med J ; 95(1119): 18-22, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30700582

ABSTRACT

BACKGROUND: Previous studies have revealed that plasma levels of free fatty acids (FFAs) are related to cardiovascular risk. However, whether FFAs could predict periprocedural myocardial injury (PMI) following percutaneous coronary intervention (PCI) in patients with stable coronary artery disease (CAD) remains unclear. PURPOSE: This study aimed to investigate the relationship of FFAs to PMI in untreated patients with CAD who underwent PCI. METHODS: A total of 374 consecutive patients with CAD without lipid-lowering treatment on admission and with normal preprocedural cardiac troponin I (cTnI) levels who underwent PCI were prospectively enrolled. The baseline characteristics were collected and PMI was evaluated by cTnI analysis within 24 hours. The relation of preprocedural FFA levels to peak cTnI values after PCI was examined. RESULTS: Preprocedural FFAs were positively correlated with peak cTnI values after PCI in both simple regression model (ß=0.119, p=0.021) and multiple regression model (ß=0.198, p=0.001). Patients with higher FFA levels had higher postprocedural cTnI levels compared with those with normal FFA levels (0.27±0.68 ng/mL vs 0.66±0.31 ng/mL, p=0.014). In the multivariable model, preprocedural FFA levels were associated with an increased risk of postprocedural cTnI elevation above 1× upper limit of normal (ULN, OR: 1.185, 95% CI 0.997 to 1.223, p=0.019) up to 10× ULN (OR: 1.132, 95% CI 1.005 to 1.192, p=0.003) . CONCLUSIONS: The present study first suggested that elevated FFA levels were associated with an increased risk of PMI in untreated patients with CAD. Further study with large sample size may be needed to confirm our findings.


Subject(s)
Coronary Artery Disease/blood , Coronary Artery Disease/surgery , Fatty Acids, Nonesterified/blood , Intraoperative Complications/blood , Percutaneous Coronary Intervention , Biomarkers/blood , Female , Humans , Male , Middle Aged , Perioperative Period , Predictive Value of Tests , Prospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...